Based on the CLSA Premium Ltd stock forecast from 0 analysts, the average analyst target price for CLSA Premium Ltd is not available over the next 12 months. CLSA Premium Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CLSA Premium Ltd is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, CLSA Premium Ltd’s stock price was HKD 0.07000000000000001. CLSA Premium Ltd’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +12.90% over the last year.
No recent analyst target price found for CLSA Premium Ltd
No recent average analyst rating found for CLSA Premium Ltd
Company Overview CLSA Premium Ltd
CLSA Premium Limited, an investment holding company, sells healthcare products in Australia and Hong Kong. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bullion, and other trading services. In addition, the company provides management services. It serves independent traders, fund managers, professional asset management institutions, financial institutions, foreign trade businesses, and banks. The company was formerly known as KVB Kunlun Financial Group Limited and changed its name to CLSA Premium Limited in November 2019. CLSA Premium Limited was incorporated in 2010 and is headquartered in Hong Kong, Hong Kong. CLSA Premium Limited is a subsidiary of CITIC Securities International Company Ltd. Read Less
CLSA Premium Limited, an investment holding company, sells healthcare products in Australia and Hong Kong. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bulli...Read More
Frequently Asked Questions About CLSA Premium Ltd (6877:HK) Stock
Stock Target Advisor's fundamental analysis for CLSA Premium Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 6877:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 6877:HK's stock to indicate what its average analyst target is.
6877:HK stock's Price/Earning ratio is 7.00.
Our analysis grades 6877:HK stock's Price / Earning ratio at D+. This means that 6877:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Capital Markets sector in the HK exchange.
Based on this 6877:HK may be fairly valued for its sector
The last closing price of 6877:HK's stock was HKD 0.07.
The most recent market capitalization for 6877:HK is HKD 0.14B.
Unfortunately we do not have enough analyst data on 6877:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CLSA Premium Ltd's stock.
As per our most recent records CLSA Premium Ltd has 13 Employees.
CLSA Premium Ltd's registered address is One Pacific Place, Hong Kong, Hong Kong.
You can get more information about it from CLSA Premium Ltd's website at https://www.clsapremium.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 6877:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
